PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care- Comparing Infliximab to Methotrexate and Systemic Steroids
Abstract
Authors
W.V. Padula T. Yilmaz M. Cordero-Coma